Claim/exemption information - Registry number 3642585

Disclose a statement to the effect that the actual concentration is withheld as a trade secret, where prescribed concentration ranges are used.

Disclose an adequate product odour.

Disclose either the name of the symbol or the symbol itself for each of the applicable product hazard classifications, specifically “exclamation mark”.

Disclose inhalation, ingestion, skin contact and eye contact as likely routes of exposure.

Disclose the HMIRA registry number and date of decision granting the exemption.

Disclose the additional hazard classifications for the product (see appendix 1).

Disclose the common name and synonyms for the ingredients listed in section 3 of the SDS.

Disclose the conditions to avoid.

Disclose the correct and complete LD50 values (see appendix 5).

Disclose the delayed and immediate effects, and chronic effects from short-term and long-term exposure.

Disclose the flammability of the product.

Disclose the hazard statements for each of the product hazard classification categories or subcategories (see appendix 2).

Disclose the information on personal precautions, protective equipment and emergency procedures in section 6 of the SDS.

Disclose the most important symptoms and effects, whether acute or delayed in section 4 of the SDS.

Disclose the precautionary statements for each of the product hazard classification categories or subcategories (see appendix 2).

Disclose the product oral acute toxicity estimate (ATE) of 843 mg/kg (0% unknown).

Disclose the reactivity of the product.

Disclose the relevant conditions for safe storage (see appendix 4).

Disclose the relevant first-aid measures (see appendix 3).

Disclose the relevant precautions for safe handling (see appendix 4).

Disclose the restrictions on use.

Remove all forward slashes or diagonal marks in precautionary statements for which a choice is to be made.